The pharma major, part of the Nifty 50 index, said its net profit stood at ₹1209.8 crore in Q3 FY26 as against ₹1413.3 crore in the same period a year ago.
Recent Posts
- L&T Tech to sell smart world portfolio to AM Group-backed AMI Paradigm Solutions
- Gold prices today: Check live rates of 24K, 22K, 18K gold in Mumbai, Delhi, Bengaluru and other cities on March 26
- Nifty Metal index falls over 8% in one month amid US-Iran war; Analysts recommend buy-on-dips in metals stocks
- IndusInd Bank launches new scheme to park and reinvest capital gains; details here
- Central Mine Planning IPO listing on Monday: Here’s what GMP signals ahead of stock market debut